Hidradenitis suppurativa, a chronic inflammatory skin condition, remains one of medicine's most frequently misdiagnosed disorders. The disease produces painful, boil-like lumps in friction-prone areas like armpits and the groin, often with interconnected tracts forming beneath the skin. Yet patients routinely receive wrong diagnoses that delay proper treatment.
Seven conditions commonly masquerade as HS. Acne ranks first because both create inflamed bumps, though HS lesions run deeper and don't respond to standard acne treatments. Cysts appear similar but lack the drainage and interconnected tunneling characteristic of HS. Ingrown hairs cause localized bumps that resolve once the hair emerges; HS persists and worsens without treatment.
Folliculitis, an infection of hair follicles, creates surface inflammation that antibiotics typically resolve. HS, by contrast, penetrates deeper tissue layers and requires long-term management. Boils present as painful nodules but remain isolated; HS develops recurrent lesions across multiple sites. Herpes causes vesicles and blistering with a predictable timeline, whereas HS follows an unpredictable chronic pattern.
The distinction matters profoundly. Misdiagnosis leads to inappropriate therapies that fail to address the underlying condition. A patient treated for acne with topical retinoids wastes months while HS progresses. Someone given antibiotics for folliculitis receives temporary relief at best.
Dermatologists experienced with HS recognize the telltale patterns. The disease typically emerges after puberty, clusters in skin folds, and often runs in families. Repeated infections in the same spots signal HS rather than isolated incidents of acne or boils.
Early accurate diagnosis opens access to effective treatments. Biologic medications targeting specific immune pathways show genuine benefit